Latest news and views tagged IP
RSS
In 2010, the High Court was asked to consider whether a marketing campaign and rebranding by Asda in relation to its optician service infringed trade marks held by Specsavers. Many of Specsavers’ claims...
“32″ and “red” marks appeal rejected by Court of Appeal – WHG (International) Ltd v 32 Red Plc, Court of Appeal
In February 2011, the High Court ruled that two European Community Trade Marks for the “32RED” word and a figurative trade mark comprising “32” and “red” had been infringed by “32Vegas”...
Will European Stem Cell Ruling Stifle Research?
My commentary on patenting stem cell techniques was published by LexisNexis and is available to view here.
PRS for Music launches consultation to reduce licence fees for amateur sports clubs
PRS for Music, an organisation which collects and pays royalties to its members for the exploitation of their musical works, has launched a consultation into the licence fees it charges amateur sports...
Sticky situation as gelled honey medical dressing patent ruled to be valid – Apimed Medical Honey Ltd (a New Zealand company) v Brightwake Ltd (trading as Advancis Medical), Court of Appeal
Apimed had successfully registered a European patent for a medical dress which combined honey with a gelling agent. The Patents County Court (PCC) had ruled that the patent was invalid for obvious in light...
Cartoon fun for the BBC but designer bounced out and loses Kerwhizz – Michael Mitchell v BBC, Patents County Court
Michael Mitchell (MM) had designed various characters for use in an animated programme for children’s television, which he called the “Bounce Bunch”. He sent a proposal to the BBC in the hope that...
Court rules that there is copyright in the aspects of London tourism photo and not just the exact photo itself – Temple Island Collections v New English Teas, Patents County Court
Temple Island Collections had taken a particular photo to use on its London tourism merchandise. The photo included a red London bus on a bridge and framed by a building, with the bus roughly in scale...
Protect Your Position – Bristol-Myers buys Inhibitex for $2.5 billion
With the Patent Cliff looming and the lack of new drugs to fill the void keeping big Pharma bosses awake at night, we are seeing new strategies emerging in an attempt to off see the gloom and doom predictions...
AstraZeneca takes step forward to find partners to avoid effects of looming Patent Cliff
AstraZeneca, the UK's second biggest pharmaceutical company, has taken steps to counteract the severe consequences of the Patent Cliff. The Patent Cliff is the name given to the imminent loss of revenues...
European Court advisor in SAS v WPL case says functions of software program can be copied but not the underlying code
SAS had developed analytical software called the SAS System over a number of years and was a giant in the market for software that enabled users to carry out analysis of data. One key element was its own...